Physician profile
Sameh Abou Ward
NPI 1215987938
$6,199.84
in general payments reported to CMS, 2019-2025
27 companies · $705 in 2025
The $705 reported for 2025 was more than what a typical Interventional Pain Medicine provider received nationally (typical 2025 total: $676).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,004 · 2020: $416 · 2021: $709 · 2022: $1,642 · 2023: $1,460 · 2024: $264 · 2025: $705.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,429.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,428.88 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $2,548.28 | 2021-2025 | Intellis Adaptivestim, Inceptiv, Kyphon Express II Kyphopak Tray |
| Medtronic USA, INC. | $702.84 | 2019-2020 | |
| Collegium Pharmaceutical, INC. | $588.14 | 2019-2025 | Belbuca, Xtampza |
| Nevro Corp. | $458.58 | 2019-2024 | Senza |
| Spr Therapeutics, INC | $418.25 | 2023 | Sprint Pns System |
| Boston Scientific Corporation | $313.91 | 2019-2025 | Wavewriter Alpha Prime 16, General - Pain Management |
| Abbott Laboratories | $188.32 | 2022-2023 | Proclaim |
| Scilex Pharmaceuticals INC. | $180.77 | 2019-2024 | Ztlido |
| Globus Medical, INC. | $116.19 | 2025 | Omnia |
| Biodelivery Sciences International, INC. | $94.76 | 2019-2021 | |
| Pacira Therapeutics, INC. | $76.06 | 2019-2020 | |
| Tersera Therapeutics LLC | $73.56 | 2019 | |
| Stimwave Technologies Incorporated | $50.00 | 2019 | |
| Si-Bone, INC. | $45.77 | 2019-2025 | |
| Arbor Pharmaceuticals, INC. | $45.36 | 2022 |
Show all 27 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $43.90 | 2021 | |
| Amgen INC. | $37.21 | 2025 | Evenity |
| Fidia Pharma USA INC. | $36.43 | 2022-2025 | Hymovis, Triluron |
| Alexion Pharmaceuticals, INC. | $26.38 | 2019 | |
| Zyla Life Sciences, INC. | $24.41 | 2019 | |
| Averitas Pharma INC. | $24.06 | 2023 | Qutenza |
| Daiichi Sankyo INC. | $23.87 | 2019 | |
| Shionogi INC | $20.17 | 2019 | |
| Curonix LLC | $17.51 | 2025 | Pns Freedom-4a Permanent Neurostimulator Receiver Kit Channel A |
| Nalu Medical, INC. | $17.13 | 2021 | |
| Ibsa Pharma INC. | $14.49 | 2024 | Tirosint, Licart |
| Assertio Therapeutics, INC. | $13.49 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sameh Ward listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.